Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Intellectual Property Litigation
  • Life Sciences
  • Patents
  • Healthcare Intellectual Property Protection and Commercialization
Contact InfoTelephone: 613.369.4783
Fax: 613.230.8842
University Queen's University, B.Sc., Hons., 1997
Law SchoolDalhousie University, LL.B., 2001
Admitted2002, Ontario; registered Patent Agent

Professional Involvement

•Member, Canadian Bar Association; Chair, Newsletter Committee, National Intellectual Property Section
•Member, County of Carleton Law Association
•Member, Intellectual Property Institute of Canada, Litigation Committee
•Member, American Intellectual Property Law Association
•Member, American Bar Association


Chantal Saunders specializes in intellectual property, with an emphasis on patent litigation and particularly pharmaceutical litigation under the Patented Medicines (Notice of Compliance) Regulations. She is a lawyer and registered patent agent in the Ottawa office of Borden Ladner Gervais LLP. Her practice also involves copyright and trademark infringement litigation, and Access to Information Act matters. She has appeared before the Federal Courts on patent, trademark and copyright matters. Chantal also advises clients with respect to data protection, and issues arising in respect of the Patent Register, and the Patented Medicine Prices Review Board.

Publications & Presentations

Chantal is a frequent blogger on the “ BLG Not-for-Profit and Charity Law in Canada Blog ”. This Blog is intended to be of value to anyone in Canada who has any involvement with Not-For-Profit Organizations or Charities.
Subscribe to this blog

•Contributing Author and Co-Editor, BLG's Intellectual Property Weekly Abstracts Bulletin.
•Co-Author, Court Guidance Needed Under Sound Prediction Doctrine, Drug Development & Outsourcing Guide 2015, Contact Canada (with Beverley Moore).
•Author, Examinations for Discovery, Intellectual Property Disputes: Resolutions and Remedies, Carswell, 2003-present (with Kevin LaRoche; 2012 supplement).
•Co- Author, Sound Prediction in Canada: The Promise is Still Important, Drug Development & Outsourcing Guide 2014, Contact Canada (with Beverley Moore).
•Author, Changing Standards Re Patent Utility Problematic for Industry, Drug Development & Outsourcing Guide 2012, Contact Canada.
•Contributing Editor, Canadian Food and Drug Legislation & Commentary, 2012 Edition, LexisNexis Canada, 2011.
•Author, Sufficiency of Disclosure and Sound Prediction Requirements in Canada, IPO Committee Newsletter, August 2011 (with Beverley Moore).
•Author, The Canadian Biotechnology Public Policy Agenda, Biotechnology Focus, September 2011 (with Beverley Moore and Jeffrey Graham).
•Contributing Author, Life Sciences & Chemical Patent Practice in Canada: A Practical Guide, 3rd edition, Borden Ladner Gervais LLP, 2011, available free of charge at

Rankings & Recognitions

•S elected by peers for inclusion in the 2016 and 2015 editions of The Best Lawyers in Canada (Intellectual Property Law).
•Recognized in the 2016 edition of the Legal 500 Canada (Intellectual Property).

Reported CasesRepresentative Work; Appeared before the Federal Court and the Federal Court of Appeal. Acting as counsel for innovator companies in proceedings brought pursuant to the Patented Medicines (Notice of Compliance) Regulations. Acting as counsel in patent infringement and patent impeachment actions. Acting as counsel in trademark infringement and expungement proceedings. Acting as counsel in a copyright infringement action. Acting as counsel for innovator companies in judicial review proceedings relating to listing of patents on the Patent Register. Advising clients with respect to data protection, listing patents on the Patent Register and reporting patents to the Patented Medicine Prices Review Board.

Documents by this lawyer on

Subscribe to this feed

Gilead Has Successfully Obtained a Declaration of Invalidity of a Patent that It Reasonably Expected Would Be Asserted Against It
Adrian J. Howard,Beverley Moore,Chantal Saunders, November 24, 2015
The Federal Court has allowed Gilead's claim to invalidate Idenix's ‘191 patent on the grounds of insufficient disclosure and lack of demonstrated utility/sound prediction. Idenix's counterclaim that Gilead's ‘657 Patent is invalid for anticipation was dismissed.

Registration for Speed Queen Expunged on Appeal for Not Showing Evidence of Use
Adrian J. Howard,Beverley Moore,Chantal Saunders, November 10, 2015
Alliance has successfully appealed a decision of the Federal Court (2014 FC 1224) that upheld a decision of the Registrar of Trademarks (2013 TMOB 218) which confirmed the registration of Whirlpool's trademark SPEED QUEEN.

Use of ABSOLUTE SECURITY for use with Software Found to Infringe ABSOLUTE
Adrian J. Howard,Beverley Moore,Chantal Saunders, November 10, 2015
Absolute had registered ABSOLUTE for use in association with software and services in 2003, and has registered four other marks containing the word absolute. Valt.X began using the term ABSOLUTE SECURITY in association with its software in 2012.

Profile Visibility
#20 in weekly profile views out of 3,330 lawyers in Ottawa, Ontario
#14,342 in weekly profile views out of 1,733,233 total lawyers Overall

Office Information

Chantal Saunders

100 Queen Street, Suite 1100
OttawaON K1P 1J9


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now